DNTH Dianthus Therapeutics, Inc.
Healthcare$86.63+0.00%OpenMarket Cap: $3.62B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$111.91
Target (Median)
$120.00
Target Range
$55.00 - $145.00
Upside from current price: 29.2%
Rating Distribution
0 Strong Buy16 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-06 | Wedbush | maintain | Outperform | Outperform |
| 2026-03-12 | Wedbush | maintain | Outperform | Outperform |
| 2026-03-10 | Raymond James | upgrade | Strong Buy | Outperform |
| 2026-03-10 | Baird | maintain | Outperform | Outperform |
| 2026-03-10 | Clear Street | maintain | Buy | Buy |
| 2026-03-09 | Truist Securities | maintain | Buy | Buy |
| 2026-03-09 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-09 | Oppenheimer | maintain | Outperform | Outperform |
| 2026-03-04 | Guggenheim | maintain | Buy | Buy |
| 2026-02-02 | Jefferies | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-4.45 | $1.7M | 9 |
| Sun Dec 31 | $-4.94 | $15.7M | 11 |
| Mon Dec 31 | $-3.13 | $195.7M | 4 |
| Tue Dec 31 | $2.32 | $618.3M | 4 |